slides · global inventory
Roadmap
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 3,235
Current window 2,101-2,130
Pages 108
Rows per page 30
Slide type
2,101-2,130 of 3,235
12
The slide outlines a standard clinical trial dose escalation design (3+3) for a radiopharmaceutical.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Market Opportunity1 hit
16
The slide uses a process flow diagram to map out different study arms and their respective patient cohorts.Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
10
The slide uses a split-screen visual metaphor to contrast the two product categories.Gogoro | Investor Presentation Deck | 30 slides · Gogoro
Pitch deck Investor relations 1 hit
20
The slide uses a temporal progression framework to illustrate market maturity and adoption.Hexagon Purus | Investor Presentation Deck | 33 slides · Hexagon Purus
Conference presentation Investor relations Beat · Market SizeLoop · Quick Win Big Bet1 hit
20
The slide uses a combination of bar charts and process flow diagrams to illustrate growth and efficiency targets.Hugo Boss | Investor Presentation Deck | 104 slides · Hugo Boss
Conference presentation Investor relations Beat · Solution1 hit
45
The slide uses a value chain structure to map specific digital initiatives (e.g., Digital Twin, Metaverse) to business functions.Hugo Boss | Investor Presentation Deck | 104 slides · Hugo Boss
Conference presentation Investor relations Beat · FinancialsLoop · Voice Of Customer1 hit
10
Uses a linear process flow diagram to illustrate product evolution.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations 1 hit
12
The slide uses a diagonal timeline to represent continuous innovation, culminating in a callout about IP strength.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations 1 hit
11
The slide uses a concentric circle/funnel-like progression to illustrate growth stages.Hyperfine | Investor Presentation Deck | 24 slides · Hyperfine
Conference presentation Investor relations Beat · Roadmap1 hit
15
Hyperfine | Investor Presentation Deck | 24 slidesHyperfine | Investor Presentation Deck | 24 slides · Hyperfine
Conference presentation Investor relations 1 hit
04
The slide uses a vertical timeline structure to organize clinical catalysts by asset.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Problem1 hit
07
The slide uses a Gantt-style visualization to show the progress of various drug candidates across different clinical phases.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Solution1 hit
35
The slide uses a chevron-based process flow to represent a phased development roadmap.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
50
The slide uses a horizontal arrow-based process flow to categorize programs by development stage (Clinical vs Preclinical).Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
58
The slide outlines a standard clinical trial progression from overview to dose escalation and expansion.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
23
Includes FDA approval precedents as a footnote to justify the clinical strategy.Immix Biopharma | Investor Presentation Deck | 60 slides · Immix Biopharma
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
26
The slide uses a two-column layout to separate milestones by drug candidate.Immix Biopharma | Investor Presentation Deck | 60 slides · Immix Biopharma
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
27
The slide uses a standard pharmaceutical pipeline table format, categorizing assets by clinical vs. preclinical status and highlighting specific clinical trial results and regulatory designations.Immix Biopharma | Investor Presentation Deck | 60 slides · Immix Biopharma
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
51
The slide uses a process flow diagram to illustrate the clinical development path for two different treatment regimens.Immix Biopharma | Investor Presentation Deck | 60 slides · Immix Biopharma
Pitch deck Investor relations Loop · Golden Circle1 hit
58
The slide uses a serpentine process flow (1-5 left-to-right, 6-10 right-to-left).Immix Biopharma | Investor Presentation Deck | 60 slides · Immix Biopharma
Pitch deck Investor relations Loop · Golden Circle1 hit
22
Includes a footnote citing FDA approval precedents for similar single-arm studies.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · ActionLoop · David Goliath1 hit
25
The slide uses a two-column layout to separate milestones by drug candidate.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
26
The slide uses a standard pharmaceutical pipeline table format with clinical and preclinical segments.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
47
Shows two parallel tracks: monotherapy and combination therapy with tislelizumab.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
23
Includes FDA approval precedents as a footnote to justify the clinical strategy.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations Beat · Roadmap1 hit
26
The slide uses a two-column layout to separate milestones by drug candidate.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations Beat · Market Sizing1 hit
27
The slide uses a standard pharmaceutical pipeline table format, categorizing by clinical vs preclinical status and highlighting specific regulatory designations and trial results.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations Beat · Market Sizing1 hit
48
Shows two parallel clinical development tracks: monotherapy and combination with tislelizumab.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
06
Kering | Investor Presentation Deck | 63 slidesKering | Investor Presentation Deck | 63 slides · Kering
Conference presentation Investor relations Beat · Situation & Context1 hit
06
The slide uses a standard pharmaceutical pipeline table format.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · Solution1 hit